FDA UNTITLED_LETTER - Jubilant Draximage Radiopharmacies Inc - July 03, 2017

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This UNTITLED LETTER record concerns Jubilant Draximage Radiopharmacies Inc, with an inspection on July 3, 2017, issued by the Division of Pharmaceutical Quality Operations I, covering drugs.

Company: Jubilant Draximage Radiopharmacies Inc
Inspection Date: July 3, 2017
Product Type: Drugs
Office: Division of Pharmaceutical Quality Operations I
People: Nicholas F. Lyons (Director of Compliance)
Joseph M. Huber
Marc Pfefferle
Eric Mueller

Open in Dashboard

ID · a3a86bec-8fd3-43fa-b526-4f2d81bbf3ec

Violation Codes9

FD&C Act 501(a)(2)(B)FD&C Act 502(f)(1)FD&C Act 505FD&C Act 501(a)(2)(A)21 U.S.C. 352(f)(1)21 U.S.C. 331(a)21 U.S.C. 351(a)(2)(B)21 U.S.C. 355(a)21 U.S.C. 331(k)

Full citation text and observation details available on the Dashboard.

UNTITLED LETTER

Jubilant Draximage Radiopharmacies IncJuly 3, 2017

FDA UNTITLED_LETTER - Jubilant Draximage Radiopharmacies Inc - July 03, 2017

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This UNTITLED LETTER record concerns Jubilant Draximage Radiopharmacies Inc, with an inspection on July 3, 2017, issued by the Division of Pharmaceutical Quality Operations I, covering drugs.

Company: Jubilant Draximage Radiopharmacies Inc
Inspection Date: July 3, 2017
Product Type: Drugs
Office: Division of Pharmaceutical Quality Operations I
People: Nicholas F. Lyons (Director of Compliance)
Joseph M. Huber
Marc Pfefferle
Eric Mueller

Open in Dashboard

ID · a3a86bec-8fd3-43fa-b526-4f2d81bbf3ec

Violation Codes9

FD&C Act 501(a)(2)(B)FD&C Act 502(f)(1)FD&C Act 505FD&C Act 501(a)(2)(A)21 U.S.C. 352(f)(1)21 U.S.C. 331(a)21 U.S.C. 351(a)(2)(B)21 U.S.C. 355(a)21 U.S.C. 331(k)

Full citation text and observation details available on the Dashboard.